The Company participates, through identification and strategic alliances, for opportunities to increase shareholder value with focus on growth and cash flow. The Company is considering other activities to increase shareholder value, including non-resource projects. Stand 20.02.2015
WKN: A118T0 ISIN: CA90420Y1088 Kürzel: UMBFF(OTC)   in  handelbar: Ja

Gründungsjahr: k.A. Haupthandelsplatz  Vollzogene Namenswechsel - Land   Angestellte: k.A.

True Leaf Medicine International Ltd.                                                                                                                                          Vodis Pharmaceuticals Inc